Public Release: 

Study reveals large drop in infection-related deaths following kidney transplantation

American Society of Nephrology


  • The risk of death due to infectious causes after kidney transplantation in Finland has dropped by half since the 1990s.
  • Common bacterial infections remain the most frequent cause of infection-related deaths among transplant recipients.
  • Infections are the most common non-cardiovascular causes of death after kidney transplantation.

Washington, DC (April 5, 2018) -- Since the 1990s, the risk of dying from infections after kidney transplantation has dropped by half, according to a recent analysis. The analysis, which appears in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN), also found that common bacterial infections remain the most frequent cause of infection-related death among transplant recipients.

The risk of infection is something that all nephrologists think of when a patient is considered for transplantation. Indeed, infections are the most common non-cardiovascular causes of death after kidney transplantation, likely due to patients' need for immunosuppressive medications to prevent rejection. No recent data about the infectious causes of death after kidney transplantation exist, however.

To provide an estimate on infection-related mortality among kidney transplant recipients in a modern developed country, a team led by Ilkka Helanterä, MD, PhD (Helsinki University Hospital) and Susanna Kinnunen, MD (Kuopio University Hospital) examined data on all adult recipients of a first kidney transplantation between 1990 and 2012 in Finland. Infectious causes of death were analyzed, and the mortality rates for infections were compared between two eras (1990-1999 and 2000-2012).

Among the 3249 adult recipients of a first kidney transplant in the analysis, 953 patients (29%) died during follow-up, with 204 infection-related deaths. The mortality rate due to infections was lower in patients in the more recent era than in patients in the 1990s (4.6 vs. 9.1 per 1000 person-years. A person-year is the number of years of follow-up multiplied by the number of people in the analysis.) Common bacterial infections were the most frequent cause of infection-related mortality, whereas opportunistic viral, fungal or unconventional bacterial infections rarely caused deaths after kidney transplantation. Older recipient age, higher plasma creatinine concentration at the end of the first post-transplant year, diabetes as a cause of kidney failure, longer pre-transplant dialysis duration, acute rejection, low albumin level, and earlier era of transplantation were associated with higher risks of infectious death.

"Our study shows that the risk of infectious mortality in patients with a kidney transplant is much lower than previously thought, and that the risk has dropped by half in the 2000s in our cohort despite transplanting older and sicker patients and using more powerful immunosuppression," said Dr. Helanterä. He noted that the discovery that the infections that cause death in transplant recipients are very similar to the infections that cause mortality in the general population is contrary to current thinking among experts. "In addition, surprisingly low number of infectious deaths were recorded during the first year after transplantation, and most of the infectious deaths occurred late, several years after transplantation."


Study co-authors include Pauli Karhapää, MD, PhD, Auni Juutilainen, MD, PhD, and Patrik Finne, MD, PhD.

Disclosures: The authors reported no financial disclosures.

The article, entitled "Secular Trends in Infection-Related Mortality after Kidney Transplantation," will appear online at on April 5, 2018, doi: 10.2215/CJN.11511017.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has nearly 18,000 members representing 112 countries. For more information, please visit or contact the society at 202-640-4660.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.